tiprankstipranks

Elicio Therapeutics price target raised to $11 from $10 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Elicio Therapeutics to $11 from $10 and keeps a Buy rating on the shares. The analyst says ELI-002 2P clinical data appears promising. The firm looks forward to the initial ELI-002 7P results in the first half of 2024.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on ELTX:

Disclaimer & DisclosureReport an Issue